Patents by Inventor Markus Ribbert

Markus Ribbert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant glycoproteins with reduced antennary fucosylation
    Patent number: 11193156
    Abstract: The present invention relates to methods for reducing antennary fucosylation of complex N-glycans in recombinantly expressed glycoproteins, cell lines that can be used in said methods, respective recombinant glycoproteins, and methods for expressing the same in said cell lines.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: December 7, 2021
    Assignee: Cevec Pharmaceutical GmbH
    Inventors: Hanns-Martin Schmidt, Markus Ribbert, Gudrun Schiedner, Silke Wissing, Jens Wölfel
  • Recombinant Glycoproteins with Reduced Antennary Fucosylation
    Publication number: 20200032311
    Abstract: The present invention relates to methods for reducing antennary fucosylation of complex N-glycans in recombinantly expressed glycoproteins, cell lines that can be used in said methods, respective recombinant glycoproteins, and methods for expressing the same in said cell lines.
    Type: Application
    Filed: March 15, 2018
    Publication date: January 30, 2020
    Applicant: Cevec Pharmaceutical GmbH
    Inventors: Hanns-Martin Schmidt, Markus Ribbert, Gudrun Schiedner, Silke Wissing, Jens Wölfel
  • SELF COUPLING RECOMBINANT ANTIBODY FUSION PROTEINS
    Publication number: 20140023592
    Abstract: A compound comprising three components A, B, and C, which components are covalently bound forming the compound having the structure A-B-C wherein component A has a specific binding affinity for antigens, component B is covalently linked to component A component C is a compound having an alkylated purine or pyrimidine moiety such as guanine, cytosine or a Coenzyme A moiety and linked thereto a moiety having a physiological effect with the proviso that component B has an catalytical or acceptor activity to couple component C with covalently coupled components A-B.
    Type: Application
    Filed: September 30, 2013
    Publication date: January 23, 2014
    Applicants: RWTH Aachen, Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung e.V.
    Inventors: Markus Ribbert, Stefan Barth, Florian Kampmeier
  • SELF COUPLING RECOMBINANT ANTIBODY FUSION PROTEINS
    Publication number: 20100183516
    Abstract: A compound comprising three components A, B, and C, which components are covalently bound forming the compound having the structure A-B-C wherein component A has a specific binding affinity for antigens, component B is covalently linked to component A component C is a compound having an alkylated purin or pyrimidin moiety such as guanin, cytosin or a Coenzyme A moiety and linked thereto a moiety having a physiological effect with the proviso that component B has an catalytical or acceptor activity to couple component C with covalently coupled components A-B.
    Type: Application
    Filed: July 25, 2008
    Publication date: July 22, 2010
    Inventors: Markus Ribbert, Stefan Barth, Florian Kampmeier